The Global Extracellular Matrix Market Growth Accelerated By Rising Incidences Of Chronic Wounds

Extracellular Matrix Market 

 The extracellular matrix (ECM) plays an important role in regulating cell behavior ranging from adhesion, migration and proliferation. ECM-based products are used to treat chronic wounds by facilitating new tissue formation. The global extracellular matrix market is estimated to be valued at US$ 46.12 Bn in 2023 and is expected to exhibit a CAGR of 5.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market key trends:
The increasing incidences of chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers is one of the major factors driving the growth of the extracellular matrix market. It is estimated that over 463 million people worldwide suffer from diabetes, which may lead to chronic wounds if not controlled properly. Additionally, the rising geriatric population is also susceptible to chronic wounds due to increased occurrences of diseases. According to the United Nations, the global geriatric population is projected to reach 1.5 billion by 2050 from 703 million in 2019. Thus, the rise in chronic conditions will augment the demand for ECM-based products for wound healing over the forecast period.

Segment Analysis
Extracellular matrix market can be segmented on the basis of type, application and end user. Based on type, the market is divided into collagens, proteoglycans, glycoproteins and others. Among these, collagens dominates the market as it is most widely used and abundant protein in ECM. It provides strength and support to tissues and plays a vital role in cell adhesion, growth and migration.

Key Takeaways
The global Extracellular Matrix market demand is expected to witness high growth during the forecast period of 2023-2030. The market is expected to reach US$ 46.12 billion by 2023 from US$ 41.15 billion in 2019, at a CAGR of 5.1%.

Regional analysis
North America region is dominating the extracellular matrix market owing to availability of advanced healthcare facilities and presence of many key players. Additionally, rising occurrence of chronic diseases has fueled demand for ECM derived therapeutics in this region. Asia Pacific is expected to witness fastest growth over forecast period. Growing medical tourism, improving healthcare infrastructure and rising awareness about ECM products are driving the market in Asia Pacific region.

Key players
Key players operating in the Extracellular Matrix market are VISUfarma, Johnson & Johnson, Otsuka Holdings Co. Ltd., OASIS Medical, Novartis AG, Sentiss Pharma Pvt. Ltd., AbbVie Inc. (Allergan PLC), Bausch Health Companies Inc., Santen Pharmaceutical Co. Ltd., and Sun Pharmaceutical Industries Ltd. among others. These players are focusing on new product launches, partnerships and geographical expansion to strengthen their market position

Get more insights on this topic: https://www.newsstatix.com/extracellular-matrix-market-industry-insights-trendsextracellular-matrix-market-2023-2030/




Comments

Post a Comment

Popular posts from this blog

The Global Coffee Market Growth Accelerated By Demand From Millennials And Gen Z Population

Image
  Coffee Market  Coffee is a popular beverage consumed worldwide for its stimulant properties and unique flavor. Coffee beans contain caffeine that stimulates the central nervous system and increases energy levels. Major products in the coffee market include whole coffee beans, ground coffee, coffee pods, instant coffee, and canned or bottled coffee. Coffee promotes mental clarity and alertness and offers antioxidant and anti-inflammatory benefits. The global coffee market is estimated to be valued at US$ 132.99 billion in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand for coffee from the millennial and Gen Z population is one of the key trends driving the growth of the global coffee market. Millennials and Gen Z are the primary consumers and account for over 50% of total coffee consumption globally. These younger demographics v...
Read more

The Global Ammonium Nitrate Market Growth Accelerated By Rising Demand From Agriculture Industry

Image
Ammonium Nitrate Market   Ammonium nitrate is an extensively used fertilizer, which is inexpensive and highly effective. It contains nitrogen, a major nutrient needed for plant growth and development. It provides plants with a continuous and balanced supply of nitrogen which helps in increasing crop yields. The ammonium nitrate market is driven by the growing agriculture sector across the globe. The increasing global population has accelerated the demand for food, resulting in high usage of for boosting agricultural production. The global ammonium nitrate market is estimated to be valued at US$ 21.18 Mn in 2023 and is expected to exhibit a CAGR of 4.5% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market key trends: The increasing demand from agriculture is one of the major trends fueling the growth of the ammonium nitrate market. Agriculture accounts for over 80% of the ammonium nitrate consumption globally....
Read more

The Global Biopharmaceuticals Market Growth Accelerated By Innovation In Product Development

Image
  Biopharmaceuticals Market  Biopharmaceuticals including monoclonal antibodies, vaccines, stem cell and gene therapy have significantly improved the treatment of various life-threatening diseases like cancer, infectious diseases and rare genetic disorders. These biologics are developed in living systems and are highly complex entities. The global Biopharmaceuticals Market is estimated to be valued at US$ 397.24 Bn in 2023 and is expected to exhibit a CAGR of 9.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: One of the key trends driving the growth of the biopharmaceuticals market is the continuous innovation in the development of novel products. Biopharmaceutical companies are extensively investing in research and development to come up with more effective and targeted treatment solutions. They are leveraging advanced technologies like gene therapy and cellular therapies to develop next-g...
Read more